January 20, 2026

Inflammatory pathway reveals targetable weakness in hard-to-treat blood cancer

by Indiana University edited by Robert Egan Editors’ notes The GIST Add as preferred source Kate Ho is working in the lab. Credit: Indiana University New research co-led by Indiana University School of Medicine scientists has exposed a vulnerability in acute myeloid leukemia by identifying the blood cancer’s reliance on a specific signaling pathway involved in the […]

Inflammatory pathway reveals targetable weakness in hard-to-treat blood cancer Read More »

Scientists design artificial pain receptor that senses pain intensity and self-heals

January 20, 2026 / Research update / InnovateMed Author / artificial pain receptor, pain receptor

by Sanjukta Mondal, Phys.org edited by Gaby Clark, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Biological and artificial nociceptive nerves with the capability of pain rating. Credit: Advanced Functional Materials, 2025. DOI: https://doi.org/10.1002/adfm.202528900 All over the body are tiny sensors called nociceptors whose job is to spot potentially harmful stimuli and send warning

Scientists design artificial pain receptor that senses pain intensity and self-heals Read More »

58% of patients affected by 2022 mpox outbreak report lasting physical symptoms

January 20, 2026 / Research update / InnovateMed Author / mpox

by American College of Physicians edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain A cohort study of over 300 adults either diagnosed with mpox between May 2022 to January 2023 (post-MPX) or who were at risk but never infected (no-MPX) found that more than half of

58% of patients affected by 2022 mpox outbreak report lasting physical symptoms Read More »

Being cold doesn’t make you sick, so why are illnesses more common in winter?

January 20, 2026 / Patient education / InnovateMed Author / illness

by Manal Mohammed, The Conversation edited by Gaby Clark, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Credit: Andrea Piacquadio from Pexels Many people across cultures grow up hearing that cold weather makes you sick. Going outside without a coat, breathing in cold air, sleeping in a chilly room, getting caught in cold rain

Being cold doesn’t make you sick, so why are illnesses more common in winter? Read More »

AI model detects prediabetes using ECG data without need for blood tests

January 20, 2026 / Research update / InnovateMed Author / prediabetes

by Institute of Science Tokyo edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Institute of Science Tokyo DiaCardia, a novel artificial intelligence model that can accurately identify individuals with prediabetes using either 12-lead or single-lead electrocardiogram (ECG) data, has been developed. This breakthrough holds promise for future home-based prediabetes

AI model detects prediabetes using ECG data without need for blood tests Read More »

Machine learning can predict patients’ responses to antidepressants—while disentangling drug and placebo effects

January 20, 2026 / Research update / InnovateMed Author / antidepressant

by Ingrid Fadelli, Medical Xpress edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Characterization of structure-function covariation predicting antidepressant and placebo responses. Credit: Nature Mental Health (2025), DOI: 10.1038/s44220-025-00541-0 Depression is one of the most widespread mental health disorders worldwide, affecting approximately 4% of the global population. It is characterized by a

Machine learning can predict patients’ responses to antidepressants—while disentangling drug and placebo effects Read More »

No short cuts—but a bit of sugar—in the quest to fight cancer relapse

January 20, 2026 / Research update / InnovateMed Author / cancer relapse

by Jeff Kelley, Virginia Commonwealth University edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Credit: Virginia Commonwealth University Medical researchers typically play the long game, spending years (and years and years) exploring an idea that could move beyond the laboratory to improve human life. At Virginia Commonwealth University, Umesh Desai,

No short cuts—but a bit of sugar—in the quest to fight cancer relapse Read More »

Unusual KRAS mutation in pancreatic cancer may explain less aggressive tumors

January 20, 2026 / Research update / InnovateMed Author / pancreatic cancer

by Medical University of South Carolina edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source A new study led by Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D., at MUSC Hollings Cancer Center, sheds light on why pancreatic tumors with the KRAS G12R mutation behave differently from other KRAS-driven cancers and why

Unusual KRAS mutation in pancreatic cancer may explain less aggressive tumors Read More »

Pediatricians offer advice on dealing with warts

January 20, 2026 / Patient education / InnovateMed Author / warts

by Carolena Steinberg and Diana H. Lee edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain Warts are small, firm bumps on the skin caused by viruses from the human papillomavirus (HPV) family. Warts are common among school-aged children but can affect people of any age.

Pediatricians offer advice on dealing with warts Read More »

Most elderly cancer patients receive inappropriate drugs until final months, study finds

January 20, 2026 / Cancer, Research update / InnovateMed Author / cancer patient

by University of Tsukuba edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain Analysis of the medical records of 1,269 elderly patients with advanced cancer by researchers at the University of Tsukuba has found that more than 70% were prescribed potentially inappropriate medications (PIMs) and that the

Most elderly cancer patients receive inappropriate drugs until final months, study finds Read More »